Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Jakub Porzycki | Nurphoto | Getty Images Novo Nordisk on Wednesday reported a third-quarter beat on sales of its blockbuster weight-loss drug Wegovy and narrowed its 2024 full-year growth guidance. Company shares jumped early on Wednesday and were last up 7.7% at 9:02 a.m. London time. The Danish pharmaceutical giant said that its net profit […]